News

Cerebrovascular disease often linked to Alzheimer’s disease

20.01.20152176

Cerebrovascular disease is often associated with Alzheimer’s disease, and especially with cognitive decline, according to researchers.

Battle of the scholars 2015: who will be the first among equals?

19.01.20152757

We invite you to take part in the competition on knowledge of practice guidelines that will be based on clinical cases.

ANNEXA-R: Antidote to novel oral anticoagulant met primary endpoint

19.01.20152100

Portola Pharmaceuticals announced topline results of the phase 3 ANNEXA-R study demonstrating that andexanet alfa, an antidote to the anticoagulant effects of Factor Xa inhibitors, met the primary endpoint with high statistical significance.

New analysis finds no association between statins, cognitive impairment

16.01.20151945

A systematic review and meta-analysis of 25 randomized controlled trials yielded no significant association between statin therapy and cognitive impairment.

Delaying noncardiac surgery after stent implantation may reduce cardiac events

16.01.20151775

Risks associated with noncardiac surgery are highest in the first 6 months after coronary stent implantation, and a new study suggests that delaying noncardiac surgery for at least 6 months may yield improved outcomes in patients after stenting.

Alirocumab meets primary endpoints in ODYSSEY CHOICE trials

14.01.20152205

Sanofi and Regeneron Pharmaceuticals Inc. announced that the phase 3 ODYSSEY CHOICE I and CHOICE II trials had each met their primary efficacy endpoints for monthly treatment with alirocumab in patients with hypercholesterolemia.

Right heart dysfunction in heart failure with preserved ejection fraction

13.01.20151991

The goal of this study was to examine the haemodynamic, clinical, and prognostic correlates of right ventricular dysfunction (RVD) in HFpEF.